Novartis AG is 47.2x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $5.99 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MIRM | NVS |
|---|---|---|
| Market cap | $5.99 B | $282.64 B |
| US-listed rank | #1272 | #47 |
| Revenue (latest FY) | $521.31M | - |
| Net income (latest FY) | -$23.36M | - |
| Net margin | -4.5% | - |
| SEC filings | 612 | 947 |
Novartis AG is 47.2x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $5.99 B).
Full pages: Mirum Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.